Angiotensin II type 1 receptor blockade attenuates posttraumatic stress disorder-related chronic pain by inhibiting glial activation in the spinal cord. (15th September 2021)

• Record Type: Journal Article
• Authors: Hong, Yishun; Wu, Wenyao; Wang, Shuo; Hao, Quanshui; Zheng, Hua; Li, Shiyong; Zhang, Xianwei; Sun, Rao
• Is Part Of: Neuropharmacology. Volume 196(2021)
• Publication Date: 2021-09-15
• Subjects: Posttraumatic stress disorder -- Stress-induced hyperalgesia -- Chronic pain -- Angiotensin II type 1 receptor -- Neuroinflammation; Neuropsychopharmacology -- Periodicals; Autonomic Agents -- Periodicals; Neuropsychopharmacologie -- Périodiques; Neuropsychopharmacology; Periodicals; Electronic journals; 615.78
• DOI: 10.1016/j.neuropharm.2021.108704
• Languages: English
• ISSNs: 0028-3908

Abstract

Abstract: Clinically, posttraumatic stress disorder (PTSD) and chronic pain are highly comorbid conditions, but the underlying mechanisms of and therapeutic strategies against PTSD-related pain remain unclear. Our previous studies suggested that dysregulation of neuroinflammation contributes to the development of stress-induced hyperalgesia. Recent studies reported that angiotensin II was a 'stress-related hormone', and could induce glial activation by stimulating the type 1 receptor (AT1R). In the present study, we aimed to investigate whether AT1R blockade could attenuate mechanical allodynia induced by PTSD-like stress. Adult male rats were exposed to single prolonged stress (SPS) to establish a model of PTSD-pain comorbidity. Our results showed that SPS exposure increased the levels of angiotensin II in the hippocampus, prefrontal cortex (PFC) and spinal cord; intraperitoneal injection of losartan attenuated SPS-induced mechanical allodynia, and suppressed SPS-induced glial activation (both microglia and astrocytes) and proinflammatory cytokine expression in the PFC and spinal cord, but not in the hippocampus. We further showed that intrathecal injection of losartan also exerted anti-hyperalgesic effect and suppressed SPS-induced glial activation and proinflammatory cytokine expression in the spinal cord. These results indicated that AT1R blockade by losartan attenuated mechanical allodynia induced by PTSD-like stress, and this may be attributed to the suppression of glial activation and proinflammatory cytokine expression in the spinal cord. Although further research is warranted to verify our findings in female rodents and to assess pharmacological effects of AT1R blockade in PFC and hippocampus, our study suggested the therapeutic potential of targeting AT1R in the treatment of PTSD-related chronic pain. Highlights: SPS exposure increased the levels of Ang II in the hippocampus, PFC and spinal cord. Losartan (i.p.) attenuated SPS-induced mechanical allodynia. Losartan (i.p.) suppressed SPS-induced glial activation in the spinal cord and PFC. Losartan (i.t.) attenuated SPS-induced mechanical allodynia. Losartan (i.t.) suppressed SPS-induced glial activation in the spinal cord.